2026-05-20T03:55:24Zhttps://keep.lib.asu.edu/oai/request

oai:keep.lib.asu.edu:node-1983312025-02-25T22:55:18Zoai_pmh:alloai_pmh:repo_items

198331 https://hdl.handle.net/2286/R.2.N.198331 http://rightsstatements.org/vocab/InC/1.0/ http://creativecommons.org/licenses/by-nc-sa/4.0 2024-12 61 pages Rivadeneira, Dino Chisholm, Amber Hallisey, Jaden Stanley, Lila Horn, Maya Quenzler, Nicole Compton, Carolyn Rigoni, Adam Barrett, The Honors College Dean, W.P. Carey School of Business School of Politics and Global Studies Text This chapter explores current strategies, regulations, and policies aimed at improving compliance with human papillomavirus (HPV) vaccination. Attention is given to the regulatory approval processes, particularly the historical and legal context of HPV vaccine variants in the United States. The chapter examines the changing landscape of HPV vaccination guidelines, including age, sex, dosage, and consent requirements. It investigates the role of major policies, such as the Affordable Care Act and the Vaccines for Children Program, in promoting vaccine accessibility and reducing disparities in underserved populations. By assessing these policies’ strengths and limitations, the research highlights gaps in Medicaid coverage and inefficiencies in program management that impact HPV vaccination efforts. The role of mandates in HPV vaccine policy is considered by examining whether legal precedent and current requirements support further coercive policy. Less restrictive measures, including provider recommendations, education, and behavioral nudges, are presented as options to pressure vaccination while maintaining personal autonomy. Finally, the discussion of education, social acceptability, stigma, hesitancy, and compliance across various demographics offers insights into how governmental regulations influence vaccination decisions. HPV Vaccination Law Government Regulation Policy HPV Vaccination: Investigating Legal and Non-Legal Approaches